Skip to main content
BIOPHARMA CREDIT PLC logo

BIOPHARMA CREDIT PLC — Investor Relations & Filings

Ticker · BPCR ISIN · GB00BDGKMY29 LEI · 213800AV55PYXAS7SY24 IL Financial and insurance activities
Open in API
Filings indexed 733 across all filing types
Latest filing 2026-06-01 Director's Dealing
Country GB United Kingdom
Listing IL BPCR

About BIOPHARMA CREDIT PLC

https://bpcruk.com/

BioPharma Credit PLC is a specialist investment trust that provides debt capital to the life sciences industry. The company's primary objective is to generate long-term, sustainable income for shareholders by investing in a diversified portfolio of interest-bearing debt assets. These investments are typically secured by royalties, revenue streams, and other cash flows derived from approved pharmaceutical products and healthcare technologies. This strategy offers investors exposure to the life sciences sector through debt instruments while providing financing to companies for growth and development.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 90% confidence The document is an RNS announcement titled “Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them,” showing insider share purchases (75 ordinary shares at £0.71603) by an associate of a director. This is a personal share transaction report by a company director/executive. Therefore it falls under the Director’s Dealing category (code DIRS).
2026-06-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an RNS announcement titled “TOTAL VOTING RIGHTS” by BioPharma Credit PLC, providing the issued share capital and voting rights figures as required under FCA Disclosure Guidance and Transparency Rules. This is an official voting rights announcement rather than complete financial statements or a vote result at an AGM. Therefore it fits the Declaration of Voting Results & Voting Rights Announcements category (Code: DVA).
2026-06-01 English
Transaction in Own Shares
Transaction in Own Shares Classification · 92% confidence The document is an RNS announcement from BioPharma Credit plc detailing the purchase of its own ordinary shares into treasury, including number of shares, price range, and resulting voting rights. This clearly matches a Transaction in Own Shares (share repurchase) filing.
2026-05-26 English
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is an announcement of a share repurchase by BioPharma Credit PLC, detailing the number of ordinary shares purchased, prices, trading venue, and resulting treasury and issued share counts. This fits the definition of a ‘Transaction in Own Shares’ (POS) filing.
2026-05-22 English
Net Asset Value(s) and Monthly Factsheet
Net Asset Value Classification · 98% confidence The document is an announcement via RNS providing the latest unaudited net asset value per ordinary share for an investment fund (BioPharma Credit PLC) as of a specific date. This fits the definition of a Net Asset Value update for an investment fund. Therefore, it should be classified under Net Asset Value (NAV).
2026-05-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 85% confidence The document is an RNS announcement titled “TRANSACTION IN OWN SHARES,” detailing the company’s purchase of its own ordinary shares into treasury, including dates, share numbers, prices, and updated treasury holdings and voting rights. This matches the “Transaction in Own Shares” filing type.
2026-05-21 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.